B. Gazzard

New England Journal of Medicine · 2005–2006

A researcher in the Science corpus: 2 papers; trusts 0 researchers and is trusted by 0 researchers here, as inferred from the citation graph.

Papers from B. Gazzard's perspective

Ordered by how strongly the researchers B. Gazzard trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Enfuvirtide, an HIV-1 fusion inhibitor, for drug-resistant HIV infection in North and South America. (New England Journal of Medicine)
  2. Adverse effects of antiretroviral therapy. (The Lancet)
  3. Hepatotoxicity associated with antiretroviral therapy in adults infected with human immunodeficiency virus and the role of hepatitis C or B virus infection. (Journal of the American Medical Association (JAMA))
  4. Prediction of coronary heart disease using risk factor categories.
  5. Adjusting for multiple testing--when and how? (Journal of Clinical Epidemiology)
  6. Class-sparing regimens for initial treatment of HIV-1 infection. (New England Journal of Medicine)
  7. Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population (AIDS (London))
  8. Antiretroviral Treatment of Adult HIV Infection2010 Recommendations of the International AIDS Society–USA Panel
  9. Metabolic abnormalities and cardiovascular disease risk factors in adults with human immunodeficiency virus infection and lipodystrophy. (Clinical Infectious Diseases)
  10. The Mechanism of Insulin Resistance Caused by HIV Protease Inhibitor Therapy* (Journal of Biological Chemistry)

Their papers